• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清钙磷乘积(Ca×PO4)作为透析前患者心血管疾病风险的预测指标

Product of serum calcium and phosphorus (Ca × PO4) as predictor of cardiovascular disease risk in predialysis patients.

作者信息

Regmi Prashant, Malla Bimala, Gyawali Prajwal, Sigdel Manoj, Shrestha Rojeet, Shah Dibya Singh, Khanal Madhav Prasad

机构信息

Department of Clinical Biochemistry, Nepal Medical College, Kathmandu, Nepal.

Charite- Universitä tsmedizin Berlin, Germany.

出版信息

Clin Biochem. 2014 Jan;47(1-2):77-81. doi: 10.1016/j.clinbiochem.2013.09.012. Epub 2013 Sep 22.

DOI:10.1016/j.clinbiochem.2013.09.012
PMID:24064489
Abstract

OBJECTIVES

The mortality rate of chronic kidney disease (CKD) patients is very high due to cardiovascular diseases (CVD) which cannot be fully justified by traditional CVD markers. Since, mineral bone disorder is common in CKD, product of serum calcium and phosphorus (Ca × PO4) can be a predictor of future CVD. So, our study aims to assess the utility of higher Ca × PO4 in prediction of CVD risk in predialysis CKD patients.

DESIGN AND METHODS

150 CKD patients defined by NKF-KDOQI guideline not undergoing dialysis were recruited. Anthropometric and electrocardiographic parameters were recorded. We evaluated CVD risk by: i) Biochemical CVD markers, ii) NCEP ATP III guideline postulated risk factors and iii) Framingham risk scores.

RESULTS

Higher Ca × PO4 is associated with presence of Left Ventricular Hypertrophy, oxidative stress, microinflammation, hyperhomocysteinemia, hypercholesterolemia, hypertriglyceridemia and increased LDLc. Compared to cases with Ca × PO4 <55 mg2/dL2, cases with ≥55 mg2/dL2 had relative risk (RR) of 1.82 (95% CI 1.25-2.64) for CVD, 3.24 (95% CI 2.37-4.41) for stroke and 2.43 (95% CI 1.37-4.31) for coronary heart disease (CHD). Moreover, compared to lowest quartile of Ca x PO4, the highest quartile group had RR of 2.13 (95% CI 1.06-4.28) for CVD, 2.61(95% CI 1.80-3.75) for stroke and 2.84 (95% CI 1.15-7.0) for CHD.

CONCLUSION

In predialysis patients, higher Ca × PO4 is independent predictor of CVD risk.

摘要

目的

慢性肾脏病(CKD)患者因心血管疾病(CVD)导致的死亡率非常高,而传统的CVD标志物无法完全解释这一现象。由于矿物质骨代谢紊乱在CKD中很常见,血清钙和磷的乘积(Ca×PO4)可能是未来CVD的一个预测指标。因此,我们的研究旨在评估较高的Ca×PO4在预测未透析CKD患者CVD风险中的作用。

设计与方法

招募了150名符合NKF-KDOQI指南定义的未接受透析的CKD患者。记录人体测量和心电图参数。我们通过以下方式评估CVD风险:i)生化CVD标志物,ii)NCEP ATP III指南假定的风险因素,以及iii)弗雷明汉风险评分。

结果

较高的Ca×PO4与左心室肥厚、氧化应激、微炎症、高同型半胱氨酸血症、高胆固醇血症、高甘油三酯血症以及LDLc升高有关。与Ca×PO4<55mg2/dL2的患者相比,Ca×PO4≥55mg2/dL2的患者发生CVD的相对风险(RR)为1.82(95%CI 1.25-2.64),中风的RR为3.24(95%CI 2.37-4.41),冠心病(CHD)的RR为2.43(95%CI 1.37-4.31)。此外,与Ca×PO4最低四分位数组相比,最高四分位数组发生CVD的RR为2.13(95%CI 1.06-4.28),中风的RR为2.61(95%CI 1.80-3.75),CHD的RR为2.84(95%CI 1.15-7.0)。

结论

在未透析患者中,较高的Ca×PO4是CVD风险的独立预测指标。

相似文献

1
Product of serum calcium and phosphorus (Ca × PO4) as predictor of cardiovascular disease risk in predialysis patients.血清钙磷乘积(Ca×PO4)作为透析前患者心血管疾病风险的预测指标
Clin Biochem. 2014 Jan;47(1-2):77-81. doi: 10.1016/j.clinbiochem.2013.09.012. Epub 2013 Sep 22.
2
Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.矿物质代谢与心血管疾病发病率及死亡风险:腹膜透析患者与血液透析患者的比较
Nephrol Dial Transplant. 2006 Sep;21(9):2513-20. doi: 10.1093/ndt/gfl257. Epub 2006 Jun 24.
3
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病(未透析)患者矿物质代谢的变化
Nefrologia. 2008;28 Suppl 3:67-78.
4
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.慢性肾脏病中磷及钙磷乘积与死亡率的关系
Am J Kidney Dis. 2005 Sep;46(3):455-63. doi: 10.1053/j.ajkd.2005.05.025.
5
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.慢性血液透析患者血清磷及钙磷乘积与死亡风险的关联:一项全国性研究
Am J Kidney Dis. 1998 Apr;31(4):607-17. doi: 10.1053/ajkd.1998.v31.pm9531176.
6
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.社区中血清磷和钙水平与心血管疾病发病率的关系。
Arch Intern Med. 2007 May 14;167(9):879-85. doi: 10.1001/archinte.167.9.879.
7
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).慢性肾脏病3期和4期患者的血浆甲状旁腺激素水平与心血管疾病患病率:来自肾脏早期评估项目(KEEP)的分析
Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10. doi: 10.1053/j.ajkd.2008.11.029.
8
Association of disorders in mineral metabolism with progression of chronic kidney disease.矿物质代谢紊乱与慢性肾脏病进展的关联
Clin J Am Soc Nephrol. 2006 Jul;1(4):825-31. doi: 10.2215/CJN.02101205. Epub 2006 May 17.
9
Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.调节胞质钙的因素。在腹膜透析患者脂质代谢及心血管发病率和死亡率中的作用。
Adv Perit Dial. 2001;17:29-36.
10
Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.血液透析患者矿物质异常的患病率、临床相关性及治疗费用:一项横断面多中心研究
Nephrol Dial Transplant. 2006 Feb;21(2):459-65. doi: 10.1093/ndt/gfi213. Epub 2005 Nov 1.

引用本文的文献

1
Evaluating Neutrophil Gelatinase-Associated Lipocalin in Pediatric CKD: Correlations with Renal Function and Mineral Metabolism.评估儿童慢性肾脏病中的中性粒细胞明胶酶相关脂质运载蛋白:与肾功能和矿物质代谢的相关性
Pediatr Rep. 2024 Dec 9;16(4):1099-1114. doi: 10.3390/pediatric16040094.
2
Extensive myocardial calcifications in a dialysis patient: A porcelain heart manifesting with abdominal pain.一名透析患者出现广泛的心肌钙化:一颗表现为腹痛的“瓷化心脏”。
Radiol Case Rep. 2023 Nov 22;19(2):523-530. doi: 10.1016/j.radcr.2023.10.081. eCollection 2024 Feb.
3
Early predictors of cardiac dysfunction in Egyptian children with chronic kidney disease.
埃及慢性肾病儿童心脏功能障碍的早期预测指标
Ann Pediatr Cardiol. 2019 Jan-Apr;12(1):10-17. doi: 10.4103/apc.APC_12_18.
4
Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.心肾综合征以及骨矿物质轴和贫血的作用。
Am J Kidney Dis. 2015 Aug;66(2):196-205. doi: 10.1053/j.ajkd.2014.12.016. Epub 2015 Feb 26.